5,000 Shares in Agilent Technologies Inc (NYSE:A) Bought by Stockman Wealth Management Inc.

Share on StockTwits

Stockman Wealth Management Inc. acquired a new position in shares of Agilent Technologies Inc (NYSE:A) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 5,000 shares of the medical research company’s stock, valued at approximately $373,000.

Other institutional investors also recently made changes to their positions in the company. Flagship Harbor Advisors LLC grew its stake in Agilent Technologies by 139.0% in the second quarter. Flagship Harbor Advisors LLC now owns 349 shares of the medical research company’s stock valued at $26,000 after acquiring an additional 203 shares during the period. Liberty Wealth Management LLC bought a new stake in shares of Agilent Technologies in the second quarter valued at about $29,000. Destination Wealth Management lifted its holdings in shares of Agilent Technologies by 100.0% in the first quarter. Destination Wealth Management now owns 400 shares of the medical research company’s stock valued at $32,000 after purchasing an additional 200 shares in the last quarter. Coastal Capital Group Inc. bought a new stake in shares of Agilent Technologies in the second quarter valued at about $32,000. Finally, Motco bought a new stake in shares of Agilent Technologies in the second quarter valued at about $40,000.

A number of equities research analysts recently issued reports on the company. Zacks Investment Research downgraded Agilent Technologies from a “buy” rating to a “hold” rating and set a $75.00 price target on the stock. in a research report on Monday, August 19th. ValuEngine downgraded Agilent Technologies from a “buy” rating to a “hold” rating in a research report on Friday, July 12th. Bank of America downgraded Agilent Technologies from a “buy” rating to a “neutral” rating and set a $76.00 price target on the stock. in a research report on Tuesday, July 16th. Robert W. Baird reissued an “outperform” rating and set a $82.00 price target (up previously from $79.00) on shares of Agilent Technologies in a research report on Thursday, August 15th. Finally, Needham & Company LLC increased their price target on Agilent Technologies to $92.00 and gave the stock a “buy” rating in a research report on Monday, August 19th. Six research analysts have rated the stock with a hold rating and ten have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $84.77.

Shares of A traded up $0.02 during trading hours on Tuesday, reaching $69.66. The stock had a trading volume of 141,252 shares, compared to its average volume of 2,799,573. Agilent Technologies Inc has a 12 month low of $61.01 and a 12 month high of $82.27. The stock has a market capitalization of $21.98 billion, a PE ratio of 25.03, a PEG ratio of 1.92 and a beta of 1.41. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.72 and a current ratio of 2.13. The company’s 50-day moving average is $69.83 and its two-hundred day moving average is $74.36.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Wednesday, August 14th. The medical research company reported $0.76 EPS for the quarter, beating the Zacks’ consensus estimate of $0.72 by $0.04. Agilent Technologies had a return on equity of 20.00% and a net margin of 21.06%. The company had revenue of $1.27 billion during the quarter, compared to analysts’ expectations of $1.24 billion. During the same period in the prior year, the company earned $0.67 EPS. Agilent Technologies’s revenue was up 5.6% compared to the same quarter last year. Equities analysts anticipate that Agilent Technologies Inc will post 3.08 earnings per share for the current fiscal year.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.

Featured Article: Outstanding Shares, Buying and Selling Stocks

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.